FDA Biologics (BLA & Biosimilars)Original article
FDA Scientific Public Workshop: Next-Generation Sequencing for Adventitious Agent Detection in Biologics - 09/23/2026
Neutral
AI Analysis
Summary
FDA is hosting a scientific public workshop on September 23, 2026 to discuss next-generation sequencing technologies for adventitious agent detection in biological products, bringing together subject matter experts and stakeholders to address adoption challenges.
Importance:2/10
Sentiment:
0.00
FDAworkshopNGSadventitious agent detectionbiologicsregulatory
Related Companies
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 18, 2026 3:08 PM